November 17th 2023
Experts reflect on the evolving landscape of biomarker testing in lung cancer, examining its crucial role in treatment decisions and advancements in perioperative and adjuvant therapies.
Explore the latest breakthroughs in precision medicine with a focus on biomarker testing and emerging targets in patients with non–small cell lung cancer.
December 15th 2022
Charu Aggarwal, MD, MPH, discusses treating patients with EGFR-mutant non–small cell lung cancer.
June 7th 2022
OncLive® will be LIVE with OncLive® News Network: On Location at the 2022 ASCO Annual Meeting. Each day, we will broadcast a series of interviews with top thought leaders, to learn their thoughts and reactions to data presented across oncology during the conference.
April 5th 2022
Charu Aggarwal, MD, MPH, discusses the optimal use of next-generation sequencing in molecular testing in non–small cell lung cancer.
December 15th 2021
Charu Aggarwal, MD, MPH, discusses the significance of the phase 3 IMpower010 trial in patients with PD-L1–positive non–small cell lung cancer.
September 16th 2021
Trials of interest exploring various novel therapies as chemoprotection in patients with solid tumor cancers.
Jared Weiss, MD, reacts to new measures that increase patient access and provider reimbursement to trilaciclib for patients with extensive-stage small cell lung cancer.
September 2nd 2021
Pros and cons of strategies used to manage chemotherapy-induced myelosuppression in extensive-stage small cell lung cancer.
August 26th 2021
Drs Charu Aggarwal and Jared Weiss react to the impact that chemotherapy-induced myelosuppression can have on patients with extensive-stage small cell lung cancer, as well as the overall health system.
Types of chemotherapy-induced myelosuppression that typically occur in patients with extensive-stage small cell lung cancer and considerations for treating patients based on risk factors and presentation of adverse events.
October 16th 2020
Charu Aggarwal, MD, MPH, discusses investigational biomarkers in lung cancer.
July 23rd 2020
Charu Aggarwal, MD, MPH, discusses emerging treatment approaches in ALK-positive non–small cell lung cancer.
July 27th 2018
Charu Aggarwal, MD, assistant professor of Medicine, University of Pennsylvania, discusses triplet therapy in EGFR-mutant lung cancer.
January 25th 2018
Development of effective therapies for metastatic head and neck cancer has been challenging, and progress has been slow.